AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H3-H6, 2005; doi:10.1152/ajpheart.00854.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilcox, C. S.
Right arrow Articles by Gutterman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcox, C. S.
Right arrow Articles by Gutterman, D.

COMMENTARY

2004 CARDIOVASCULAR AND KIDNEY INVESTIGATORS MEETING

Focus on oxidative stress in the cardiovascular and renal systems

Christopher S. Wilcox and David Gutterman

Cardiovascular Kidney Institute
Georgetown University
Washington, DC
E-Mail: wilcoxch{at}georgetown.edu Cardiovascular Center
Medical College of Wisconsin
Milwaukee, Wisconsin

ARTICLES IN THIS SECTION were presented at the Cardiovascular Kidney Investigators Meeting at Amelia Island, Florida held on May 28–31, 2004. A discussion of the role of oxidative stress in the cardiovascular and kidney systems raises many important but still controversial issues. Current reviews detail the increasing recognition that oxidative stress plays an important role not only in the regulation of pathological changes in the blood vessel (4, 34, 35), heart (7, 18), and kidneys (6, 23, 32), but also in regulating normal physiological adaptation of these systems (15, 26, 30, 36, 37, 4346).

Oxidative stress remains an elusive phenomenon. It is difficult even to define. It represents an excess of reactive oxygen species (ROS) in the tissues under consideration or in the whole body. This implies either an increased production of ROS, for example, by specific oxidase such as NADPH oxidase, xanthine/xanthine oxidase, various arachidonic acid monooxygenases, or the mitochondrial respiratory chain. Alternatively, it may derive from a failure to metabolize ROS. The major pathways for metabolism are superoxide dismutase (SOD), which is expressed as extracellular (EC), intracellular, and mitochondrial isoforms that metabolize superoxide anion (O2·) to H2O2. Peroxidases such as catalase and glutathione peroxidase (predominantly intracellular) further metabolize H2O2 to O2 and water. However, such a definition is highly simplistic because of the other, biologically important, ROS such as hydroxyl anion (·OH) formed from H2O2, peroxynitrate (ONOO) formed principally by the interaction of nitric oxide (NO) and O2 or ·OH, or hypochlorous acid formed by myeloperoxidase. There are multiple other reaction products with other mediators. Important interactions occur between ROS and NO where O2· not only reduces NO bioactivity by shortening its half-life but also generates highly reactive species such as ONOO that are themselves implicated in oxidative and nitrosating reactions.

No less problematic is the quantitative assessment of oxidative stress (10). At the level of the whole animal, use is often made of the appearance of oxidized end products of ROS metabolism. These end-products include lipid peroxidation products such isoprostanes, which are formed predominantly nonenzymically by the interaction of O2· with arachidonate or malondialdehyde. More stable and long-lasting products include oxidative modifications of DNA. ONOO can be assessed semiquantitatively from nitrosation of tyrosine epitopes in proteins, but the reaction products are difficult to quantify by Western blot analysis. Moreover, this reaction also is influenced by nitrase, which generates NO2 and reverses the tyrosine nitration. At the level of the isolated vessels or single cells, fluorescent probes to detect O2·, H2O2, ONOO, and NO are receiving increasing attention. A particularly promising technique is to assess the redox ratio of biologically determined products such as oxidized:reduced thiols (e.g., cysteine or homocysteine) or oxidized:reduced nucleotides (e.g., flavin adenine dinucleotide) within cells. Because the thiols are in redox equilibrium throughout the body, this is an attractive technique to sample the redox chemistry of the body or a particular tissue. However, this approach may break down where the thiol-redox pair is determined by specific enzyme regulations, for example, the oxidized:reduced ratio of glutathione is under the control of glutathione peroxidase and reductase that may be as important as the redox state in governing the thiol pair ratio. Nevertheless, assessment of appropriate redox pairs gets more directly at the problem of quantitating the redox state within the cells and tissues under study.

Initial interest in ROS as vasoactive mediators focused particularly on O2· and its interaction with NO as a mechanism to explain endothelial dysfunction (12, 16, 31) and renal vasoconstriction (2, 3, 31, 42), for example, in ANG II-induced hypertension (1, 27). Mori and Cowley (24) had shown that O2· generated by NADPH oxidase under the influence of ANG II modifies tubulovascular NO cross-talk in the outer medulla. In this issue, Pallone and colleagues (48) report their study of microvascular O2· and NO generation assessed directly in vasa recta dissected from the rat kidney medulla. They show that, unlike renal afferent arterioles (38), chronic ANG II does not stimulate O2· generation in vasa recta and indeed enhances NO generation leading to a diminished ANG II constriction.

Increasing interest focuses on the role of H2O2 (1922). This can be active itself (20) or be further metabolized to highly reactive species such as ·OH. In this issue, Hatoum et al. (11) report their studies of human submucosal intestinal vessels where H2O2 is a vasoactive mediator. One pathway is for H2O2 to act as an endogenous endothelium-derived hyperpolarizing factor (EDHF). H2O2 was considered to be generated in endothelial cells and to activate potassium channels in vascular smooth muscle cells, thereby causing hyperpolarization and diminished reactivity. The source of H2O2 in the endothelial cells, its transmembrane passage, and the details of its interaction with specific channels on vascular smooth muscle cells were unclear. The new findings of Hatoum et al. (11) are that endothelial production of H2O2 does indeed occur in response to acetylcholine but that H2O2 is not simply on EDHF in their vessels. They provide evidence that H2O2 functions rather to release an EDHF. Increasing evidence suggests that EDHF may be at least as important as endothelium-derived relaxing factor-NO in the regulation of tone and contractility of the resistance vessels, whereas NO is generally of predominant importance in the large conduit vessels.

Of special importance is the regulation of NADPH oxidase activity during prolonged ANG II exposure or other physiological stimuli. Gupte et al. (9) compare NADPH-dependent O2· generation in bovine pulmonary and coronary arteries during adaptation to hypoxia. An important finding is that differences in oxidase activities relate not only to expression of the components of NADAH oxidase but rather to the availability of the substrate NADPH, which is generated by glucose 6-phosphate dehydrogenase (8, 25). In this special section, Welch et al. (41) report their studies of NADPH oxidase activity, p22phox, and EC-SOD expression in the rat renal cortex. They confirm that prolonged ANG II infusion increases NADPH oxidase activity and p22phox and reduces EC-SOD. Remarkably, concurrent infusion of a permeant SOD mimetic to obviate oxidative stress prevents all these changes. They conclude that ROS themselves are autocatalytic and induce further ROS generation in the kidney via increase p22phox and reduced EC-SOD, thereby contributing to the sustained effects of ANG II on ROS accumulation during a slow pressor response.

In other articles on this issue, Weber et al. (39) and Laude et al. (17) report their studies of transgenic mice overexpressing p22phox. These mice have a twofold increased vascular expression of p22phox and H2O2, accompanied by increased NOX-1 (13). Yet, despite this, the blood pressure and endothelium-dependent relaxation responses are intact. This is related to enhanced endothelial NO synthase (eNOS) and EC-SOD expression, leading to an enhanced capacity to generate NO. They conclude that ROS evoke a compensatory increase in eNOS and SOD that can maintain normal vascular function and hemodynamics (17). Moreover, their studies of vascular smooth muscle cell hypertrophy in this model show that ANG II causes an exaggerated structural response in the blood vessels of the p22phox overexpressing mice. Weber et al. (39) conclude that p22phox and NADPH oxidase potentiate smooth muscle cell hypertrophy. Their findings raise important questions concerning the signaling by ROS. In this issue, Yang et al. (47) report their study of the role of phospholipase D (PLD) in ROS generation in the mouse kidney. Their studies in the dopamine 5 (D5) receptor knockout mouse associate the hypertension in this model with increased PLD expression that engages NADPH oxidase activity. The potential relevance of NO and ROS in explaining gender differences in renal injury are explored in the study by Ji et al. (14). Their studies in the renal-wrap model of hypertension show similar degrees of hypertension, yet enhanced indexes of renal damage in male rats that these authors relate to gender-specific regional differences in NOS expression within the kidneys.

Many new avenues of study of ROS are emerging. These include competition of NO with O2 in setting the level of cellular respiration and oxygen usage and hence the oxygen tension of the tissues. Consequent activation of the hypoxia inducible factor may engage a further set of translational events that could dictate altered gene expression and a new physiological and pathophysiological environment. Welch et al. (41) report their studies which confirm (40) that the kidneys of chronically ANG II-infused rats use O2 inefficiently for Na+ reabsorption and consequently are hypoxic. They relate the hypoxia to the generation of O2· because hypoxia is reversed by confusion of an SOD mimetic (41). In this issue, Fitzpatrick et al. (5) report that a period of adaptation to hypoxia after birth confers prolonged protection against cardiac ischemia in the rabbit. They relate this to expression of eNOS, leading to NO-dependent activation of adenosine triphosphate potassium channels (28, 29, 33).

Finally, an area of great interest is the hypothesis that ROS are proximate in multiple signaling pathways implicated in organ dysfunction or damage. Downstream from ROS are activation of proinflammatory pathways such as nuclear factor-{kappa}B that link ROS to cellular adhesion, inflammation, and cytokine production, which are key events in the pathophysiology of chronic cardiovascular and kidney diseases (Fig. 1). A hierarchy of regulation could be envisaged whereby initial damage within the heart, blood vessels, or kidneys, with secondary pathophysiological changes in neurohormones, pressures, and flows engages oxidative stress that recruits a wide range of aggressive genes, cytokines, or hormones that perpetuate the organ damage. Such a schema suggests new mechanisms whereby primary disease of one system, for example, the kidneys, can lead to secondary dysfunction of another, such as the heart (Fig. 1).



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1. Flow diagram of some pathophysiological interaction coordinated by reactive oxygen species (ROS).

 
The Cardiovascular Kidney Investigators Meeting at Amelia Island covered many of these evolving issues with focused presentations that form a special, fully refereed addition of the American Journal of Physiology-Heart & Circulatory Physiology. The meeting was jointly sponsored by the National Heart, Lung, and Blood Institute Program Project Grants (PPGs) PO1-HL-68686 (Georgetown University) and P50-HL-68769 (Medical College of Wisconsin), and a Specialized Center of Research in Myocardial Ischemia in African-Americans Grant P50-HL-065203 (Medical College of Wisconsin). Additional funds were provided by the George E. Schreiner Chair of Nephrology at Georgetown University and by unrestricted educational grants from AstraZeneca, Boehringer Ingelheim Pharmaceutical, Merck, and GlaxoSmithKlien.

The principle of the National Heart, Lung, and Blood Institute-sponsored PPGs and SCOR grants is to foster collaboration and share new ideas between investigators working in different disciplines who have committed to study a central theme. We expanded this vision to include collaboration between three competing PPG or SCOR grants that had a focus on oxidative stress. Participants included both investigators and member of the external advisory committees of these projects. Invited and informal "hot topic" presentations were made by the group during a 3-day meeting at Amelia Island Plantation, Florida.

REFERENCES

  1. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase and SODs expression. Am J Physiol Regul Integr Comp Physiol 285: R117–R124, 2003.[Abstract/Free Full Text]
  2. Chabrashvili T, Tojo A, Onozato M, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, and Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269–274, 2001.
  3. Cowley AW Jr, Mori T, Mattson D, and Zou AP. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284: R1355–R1369, 2003.[Abstract/Free Full Text]
  4. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, and Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963–974, 2000.[CrossRef][ISI][Medline]
  5. Fitzpatrick CM, Shi Y, Hutchins WC, Su J, Gross GJ, Ostadal B, Tweddell JS, and Baker JE. Cardioprotection in chronically hypoxic rabbits persists upon exposure to normoxia: role of nitric oxide synthase and KATP channels. Am J Physiol Heart Circ Physiol 288: H62–H68, 2005.[Abstract/Free Full Text]
  6. Goligorsky MS, Chen J, and Brodsky S. Endothelial cell dysfunction leading to diabetic nephropathy. Focus on nitric oxide. Hypertension 37: 744–748, 2001.[Abstract/Free Full Text]
  7. Griendling KK and FitzGerald GA. Oxidative stress and cardiovascular injury. Part II. Animal and human studies. Circulation 108: 2034–2040, 2003.[Free Full Text]
  8. Gupte SA, Arshad M, Viola S, Kaminski PM, Ungvari Z, Rabbani G, Koller A, and Wolin MS. Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries. Am J Physiol Heart Circ Physiol 285: H2316–H2326, 2003.[Abstract/Free Full Text]
  9. Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M, Edwards J, and Wolin MS. Cystolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 288: H13–H21, 2005.[Abstract/Free Full Text]
  10. Halliwell B and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142: 231–255, 2004.[CrossRef][ISI][Medline]
  11. Hatoum OA, Binion DG, Miura H, Telford G, Otterson MF, and Gutterman DD. The role of hydrogen peroxide in ACh-induced dilation of human submucosal intestinal microvessels. Am J Physiol Heart Circ Physiol 288: H48–H54, 2005.[Abstract/Free Full Text]
  12. Hatoum OA, Binion DG, Otterson MF, and Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 125: 58–69, 2003.[CrossRef][ISI][Medline]
  13. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677–683, 2004.[Abstract/Free Full Text]
  14. Ji H, Pesce C, Zheng W, Kim J, Zhang Y, Menini S, Haywood JR, and Sandberg K. Sex differences in renal injury and nitric oxide production in renal wrap hypertension. Am J Physiol Heart Circ Physiol 288: H43–H47, 2005.[Abstract/Free Full Text]
  15. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Salt intake, oxidative stress and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14: 2775–2782, 2003.[Abstract/Free Full Text]
  16. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, and Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40: 511–515, 2002.[Abstract/Free Full Text]
  17. Laude KM, Cai H, Fink B, Hoch N, Weber DS, McCann L, Kojda G, Fukai T, Dikalov S, Ramasamy S, Gamez G, Griendling KK, and Harrison DG. Hemodynamic and biochemical adaptations to vaxcular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol 288: H7–H12, 2005.[Abstract/Free Full Text]
  18. Li N, Zou AP, Ge ZD, Campbell WB, and Li PL. Effect of nitrix oxide on calcium-induced calcium release in coronary arterial smooth muscle. Gen Pharmacol 35: 37–45, 2000.[ISI][Medline]
  19. Liu Y, Terata K, Chai Q, Li H, Kleinman LH, and Gutterman DD. Peroxynitrite inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles. Circ Res 91: 1070–1076, 2002.[Abstract/Free Full Text]
  20. Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, and Gutterman DD. Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 93: 573–580, 2003.[Abstract/Free Full Text]
  21. Makino A, Skelton MM, Zou AP, and Cowley AW Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension 42: 25–30, 2003.[Abstract/Free Full Text]
  22. Miura H, Watchtel RE, Liu Y, Loberiza FR Jr, Saito T, Muira M, and Gutterman DD. Flow-induced dilation of human coronary arterioles: important role of Ca2+-activated K+ channels. Circulation 103: 1992–1998, 2001.[Abstract/Free Full Text]
  23. Modlinger P, Wilcox CS, and Aslam S. Nitric oxide, oxidative stress and progression of chronic renal failure. Semin Nephrol 24: 354–365, 2004.[CrossRef][ISI][Medline]
  24. Mori T and Cowley AW Jr. Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 42: 588–593, 2003.[Abstract/Free Full Text]
  25. Oeckler RA, Kaminski PM, and Wolin MS. Stretch enhances contraction of bovine coronary arteries via an NAD(P) oxidase-medicated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 92: 24–31, 2003.
  26. Ortiz PA and Garvin JL. Role of nitric oxide in the regulation of nephron transport. Am J Physiol Renal Physiol 282: F777–F784, 2002.[Abstract/Free Full Text]
  27. Pallone TL and Mattson DL. Role of nitric oxide in regulation of the renal medulla in normal and hypertensive kidneys. Curr Opin Nephrol Hypertens 11: 93–98, 2002.[CrossRef][ISI][Medline]
  28. Rafiee P, Shi Y, Kong X, Pritchard KA Jr, Tweddell JS, Litwin SB, Mussatto K, Jaquiss RD, Su J, and Baker JE. Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. Circulation 106: 239–245, 2002.[Abstract/Free Full Text]
  29. Rafiee P, Shi Y, Pritchard KA Jr, Ogawa H, Eis AL, Komorowski RA, Fitzpatrick CM, Tweddell JS, Litwin SB, Mussatto K, Jaquiss RD, and Baker JE. Cellular redistribution of inducible Hsp70 protein in the human and rabbit heart in response to the stress of chronic hypoxia: role of protein kinases. J Biol Chem 278: 43636–43644, 2003.[Abstract/Free Full Text]
  30. Ren Y, Garvin JL, Ito S, and Carretero OA. Role of neuronal nitric oxide synthase in the macula densa. Kidney Int 60: 1676–1683, 2001.[CrossRef][ISI][Medline]
  31. Sato A, Sakuma I, and Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 285: H2345–H2354, 2003.[Abstract/Free Full Text]
  32. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radical in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282: R335–R342, 2002.[Abstract/Free Full Text]
  33. Shi Y, Rafiee P, Su J, Pritchard KA Jr, Tweddell JS, and Baker JE. Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol 99: 173–182, 2004.[CrossRef][ISI][Medline]
  34. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248–252, 2004.[Abstract/Free Full Text]
  35. Touyz RM. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2: 98–105, 2000.[Medline]
  36. Touyz RM and Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639–672, 2000.[Abstract/Free Full Text]
  37. Ullrich V and Bachschmid M. Superoxide as a messenger of endothelial function. Biochem Biophys Res Commun 278: 1–8, 2000.[CrossRef][ISI][Medline]
  38. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego L, Umans J, and Wilcox CS. Role of oxidative stress in endothelial dysfunction and enhanced responses to Ang II of afferent arterioles from rabbits infused with Ang II. J Am Soc Nephrol 14: 2783–2789, 2003.[Abstract/Free Full Text]
  39. Weber DS, Rocic P, Mellis AM, Laude KM, Lyle A, Harrison DG, and Griendling KK. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol 288: H37–H42, 2005.[Abstract/Free Full Text]
  40. Welch WJ, Baumgärtl H, Lübbers D, and Wilcox CS. Renal oxygenation defects in the spontaneously hypertensive rat: role of AT1 receptors. Kidney Int 63: 202–208, 2003.[CrossRef][ISI][Medline]
  41. Welch WJ, Blau J, Xie H, Chabrashvili T, and Wilcox CS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 288: H22–H28, 2005.[Abstract/Free Full Text]
  42. Welch WJ and Wilcox CS. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 59: 1257–1263, 2001.[CrossRef][ISI][Medline]
  43. Wilcox CS. Reactive oxygen species: role in blood pressure and kidney function. Curr Hypertens Rep 4: 160–166, 2002.[ISI][Medline]
  44. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 179: 217–223, 2003.[CrossRef][ISI][Medline]
  45. Wilcox CS and Welch WJ. Oxidative stress: cause or consequence of hypertension? Exp Biol Med 226: 619–620, 2001.[Free Full Text]
  46. Wolin MS, Gupte SA, and Oeckler RA. Superoxide in the vascular system. J Vasc Res 39: 191–207, 2002.[CrossRef][ISI][Medline]
  47. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Bai R, Sibley DR, Felder RA, and Jose PA. D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 288: H55–H61, 2005.[Abstract/Free Full Text]
  48. Zhang Z, Rhinehart K, Solis G, Pittner J, Kwon W, Welch WJ, Wilcox CS, and Pallone TL. Chronic Ang II infusion increases NO generation by rat descending vasa recta. Am J Physiol Heart Circ Physiol 288: H29–H36, 2005.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
L. G. Sanchez-Lozada, V. Soto, E. Tapia, C. Avila-Casado, Y. Y. Sautin, T. Nakagawa, M. Franco, B. Rodriguez-Iturbe, and R. J. Johnson
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1134 - F1141.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Medhora, Y. Chen, S. Gruenloh, D. Harland, S. Bodiga, J. Zielonka, D. Gebremedhin, Y. Gao, J. R. Falck, S. Anjaiah, et al.
20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L902 - L911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. A. Wiseman, S. M. Wells, M. Hubbard, J. E. Welker, and S. M. Black
Alterations in zinc homeostasis underlie endothelial cell death induced by oxidative stress from acute exposure to hydrogen peroxide
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L165 - L177.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. A. Wiseman, S. M. Wells, J. Wilham, M. Hubbard, J. E. Welker, and S. M. Black
Endothelial response to stress from exogenous Zn2+ resembles that of NO-mediated nitrosative stress, and is protected by MT-1 overexpression
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C555 - C568.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. D. Pendergrass, D. B. Averill, C. M. Ferrario, D. I. Diz, and M. C. Chappell
Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2.Lewis rat
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1497 - F1506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Wilcox
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilcox, C. S.
Right arrow Articles by Gutterman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcox, C. S.
Right arrow Articles by Gutterman, D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.